IonQ and CCRM Launch Quantum-Biotech Partnership for Advanced Therapeutics

Reuters

12/01

IonQ and CCRM Launch <a href="https://laohu8.com/S/QMCO">Quantum</a>-Biotech Partnership for Advanced <a href="https://laohu8.com/S/LENZ">Therapeutics</a>

IonQ Inc., a leading quantum technology company, has announced a strategic partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate the development of advanced therapeutics using hybrid quantum and quantum-AI technologies. As the core technology partner across CCRM's global regenerative medicine network, IonQ will support quantum-biotech initiatives focused on bioprocess optimization, disease-modeling workflows, and quantum-enhanced simulation for advanced therapy design and manufacturing. The collaboration includes an investment commitment from IonQ and will launch initial projects in Canada and Sweden in 2026, aiming to revolutionize therapeutic development, biomanufacturing, and healthcare delivery.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IONQ Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251201706303) on December 01, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2588278847"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2588278847\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2588278847?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-01 20:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588278847","market":"us","top_or_hot":-1,"title":"IonQ and CCRM Launch Quantum-Biotech Partnership for Advanced Therapeutics","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      IonQ and CCRM Launch <a href=\"https://laohu8.com/S/QMCO\">Quantum</a>-Biotech Partnership for Advanced <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        IonQ Inc., a leading quantum technology company, has announced a strategic partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate the development of advanced therapeutics using hybrid quantum and quantum-AI technologies. As the core technology partner across CCRM's global regenerative medicine network, IonQ will support quantum-biotech initiatives focused on bioprocess optimization, disease-modeling workflows, and quantum-enhanced simulation for advanced therapy design and manufacturing. The collaboration includes an investment commitment from IonQ and will launch initial projects in Canada and Sweden in 2026, aiming to revolutionize therapeutic development, biomanufacturing, and healthcare delivery.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/IONQ\">IONQ Inc.</a> published the original content used to generate this news brief via Business Wire (Ref. ID: 20251201706303) on December 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IonQ and CCRM Launch Quantum-Biotech Partnership for Advanced Therapeutics</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIonQ and CCRM Launch Quantum-Biotech Partnership for Advanced Therapeutics\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-01 20:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      IonQ and CCRM Launch <a href=\"https://laohu8.com/S/QMCO\">Quantum</a>-Biotech Partnership for Advanced <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        IonQ Inc., a leading quantum technology company, has announced a strategic partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate the development of advanced therapeutics using hybrid quantum and quantum-AI technologies. As the core technology partner across CCRM's global regenerative medicine network, IonQ will support quantum-biotech initiatives focused on bioprocess optimization, disease-modeling workflows, and quantum-enhanced simulation for advanced therapy design and manufacturing. The collaboration includes an investment commitment from IonQ and will launch initial projects in Canada and Sweden in 2026, aiming to revolutionize therapeutic development, biomanufacturing, and healthcare delivery.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/IONQ\">IONQ Inc.</a> published the original content used to generate this news brief via Business Wire (Ref. ID: 20251201706303) on December 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IONQ","symbol_name":"IONQ Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL8CSCLZ:1","article_id":"2588278847","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588278847","pubTimestamp":1764592244,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"IonQ Inc., a leading quantum technology company, has announced a strategic partnership with the Centre for Commercialization of Regenerative Medicine  to accelerate the development of advanced therapeutics using hybrid quantum and quantum-AI technologies. As the core technology partner across CCRM's global regenerative medicine network, IonQ will support quantum-biotech initiatives focused on bioprocess optimization, disease-modeling workflows, and quantum-enhanced simulation for advanced therapy design and manufacturing. The collaboration includes an investment commitment from IonQ and will launch initial projects in Canada and Sweden in 2026, aiming to revolutionize therapeutic development, biomanufacturing, and healthcare delivery.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpre","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IONQ":"IONQ Inc.","BK4170":"电脑硬件、储存设备及电脑周边","BK4591":"室温超导概念","BK4602":"量子计算概念"},"translate_title":"IonQ和CCRM建立量子生物技术合作伙伴关系以开发先进疗法","themeId":"9d2740edf4f0b98ff0520696a67e8073","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IONQ":0.9},"content_text":"IonQ and CCRM Launch Quantum-Biotech Partnership for Advanced Therapeutics\n\n\n        IonQ Inc., a leading quantum technology company, has announced a strategic partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate the development of advanced therapeutics using hybrid quantum and quantum-AI technologies. As the core technology partner across CCRM's global regenerative medicine network, IonQ will support quantum-biotech initiatives focused on bioprocess optimization, disease-modeling workflows, and quantum-enhanced simulation for advanced therapy design and manufacturing. The collaboration includes an investment commitment from IonQ and will launch initial projects in Canada and Sweden in 2026, aiming to revolutionize therapeutic development, biomanufacturing, and healthcare delivery.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IONQ Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251201706303) on December 01, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}